BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

KV Pharmaceutical Execs Get Thousands in Bonuses


4/9/2012 7:16:05 AM

St. Louis Business Journal by Evan Binns, Reporter

KV Pharmaceutical paid two top executives nearly $379,000 in performance bonuses and stock options amid questions about the beleaguered drug company’s ability to survive.

On March 27, at meeting of KV’s board of directors, the company approved a $130,000 cash bonus for President and Chief Executive Greg Divis for fiscal 2012 performance, according to documents filed with the Securities and Exchange Commission.

Divis receives an annual base salary of $520,000, according to the company’s most recent proxy, filed in July 2011.

Chief Financial Officer Tom McHugh received a cash bonus of $65,000 for the company’s fiscal 2012 performance.




   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES